These results, along with a prior report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two assistance the concept of targeting ACKR3 as a singular approach to modulate the opioid system, which could open up new therapeutic avenues for opioid-similar